Dermapharm Holding SE (LON:0A5J)

Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	121.31	158.72	151.02	161.41	120.3
Short-Term Investments	0.59	0.82	1.48	1.76	2.52
Cash & Short-Term Investments	121.9	159.54	152.5	163.18	122.82
Cash Growth	-23.60%	4.62%	-6.54%	32.85%	5.80%
Accounts Receivable	102.18	95.41	96.72	72.52	55.52
Other Receivables	11.25	40.39	8.41	14.29	6.21
Receivables	113.43	135.8	105.13	86.81	61.72
Inventory	343.38	320.76	255.72	243.6	205.73
Prepaid Expenses	7.6	7.94	7	13.19	3.45
Other Current Assets	7.19	6.45	13.6	12.45	6.33
Total Current Assets	593.5	630.5	533.95	519.22	400.05
Property, Plant & Equipment	315.03	330.77	225.67	222.29	199.62
Long-Term Investments	21.87	25.06	36.57	105.62	60.7
Goodwill	576.38	578.52	271.32	264.73	266.27
Other Intangible Assets	406.14	441.61	212.12	217.13	235.24
Long-Term Deferred Charges	106.18	103.25	92.92	77.72	62.1
Other Long-Term Assets	0.94	0.97	0.28	0.27	0.41
Total Assets	2,080	2,161	1,413	1,407	1,224
Accounts Payable	94.79	86.64	56.1	52.1	50.37
Accrued Expenses	67.69	94.35	54.51	45.17	38.82
Short-Term Debt	0.04	0.01	0	-	-
Current Portion of Long-Term Debt	86.04	111.43	1.87	2.38	22.21
Current Portion of Leases	5.12	5	3.02	3.2	3.84
Current Income Taxes Payable	58.83	81.82	96.35	48.8	8.85
Current Unearned Revenue	1.5	1.43	0.56	0.62	1.06
Other Current Liabilities	12.91	13.82	5.38	3.35	7.72
Total Current Liabilities	326.92	394.49	217.79	155.61	132.87
Long-Term Debt	886.71	963.89	501.84	565.71	570.48
Long-Term Leases	12.35	13.25	9.72	9.01	10.28
Long-Term Unearned Revenue	11.34	11.69	9.2	9.46	9.72
Long-Term Deferred Tax Liabilities	111.7	112.39	50.52	36.06	29.95
Other Long-Term Liabilities	3.08	2.71	1.99	2.41	1.77
Total Liabilities	1,472	1,616	880.34	907.14	899.81
Common Stock	53.84	53.84	53.84	53.84	53.84
Retained Earnings	433.19	367.22	355.36	337.95	177.08
Comprehensive Income & Other	117.39	118.14	122.4	105.52	91.04
Total Common Equity	604.42	539.21	531.59	497.32	321.97
Minority Interest	3.87	5.84	0.9	2.52	2.62
Shareholders' Equity	608.3	545.05	532.49	499.83	324.58
Total Liabilities & Equity	2,080	2,161	1,413	1,407	1,224
Total Debt	990.26	1,094	516.45	580.3	606.8
Net Cash (Debt)	-868.36	-934.03	-363.95	-417.13	-483.98
Net Cash Per Share	-16.13	-17.35	-6.76	-7.75	-8.99
Filing Date Shares Outstanding	53.84	53.84	53.84	53.84	53.84
Total Common Shares Outstanding	53.84	53.84	53.84	53.84	53.84
Working Capital	266.58	236.01	316.16	363.61	267.18
Book Value Per Share	11.23	10.01	9.87	9.24	5.98
Tangible Book Value	-378.1	-480.92	48.15	15.46	-179.54
Tangible Book Value Per Share	-7.02	-8.93	0.89	0.29	-3.33
Land	247.87	252.54	171.75	163.41	147.52
Machinery	252.92	234.8	178.45	163.77	137.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.